Philippe Camus Selected Research

Philippe Camus Research Topics

Disease

4	Pneumonia (Pneumonitis) 01/2019 - 08/2010
4	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2018 - 12/2007
4	Fibrosis (Cirrhosis) 02/2015 - 11/2007
3	Neoplasms (Cancer) 01/2019 - 10/2015
3	Pulmonary Edema 07/2018 - 10/2005
3	Lung Diseases (Lung Disease) 09/2014 - 09/2004
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2014 - 04/2013
2	Bronchiectasis 01/2022 - 08/2015
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2018 - 06/2012
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 07/2018 - 09/2014
2	Hemorrhage 07/2018 - 10/2005
2	Melanoma (Melanoma, Malignant) 02/2016 - 10/2015
2	Carcinoma (Carcinomatosis) 01/2006 - 11/2004
1	Inflammation (Inflammations) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Bronchiolitis 07/2018
1	Organizing Pneumonia 07/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Hypoventilation 10/2016
1	Lymphoma (Lymphomas) 02/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2016
1	Pulmonary Hypertension 02/2016
1	Respiratory Insufficiency (Respiratory Failure) 10/2015
1	Tuberculosis (Tuberculoses) 08/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2015
1	Aspergillosis 08/2015
1	Lung Neoplasms (Lung Cancer) 08/2015
1	Pulmonary Embolism 08/2015
1	Rheumatoid Arthritis 09/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2014
1	Sarcoidosis (Schaumann Disease) 09/2014
1	Burns 01/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2010
1	Cicatrix (Scar) 11/2007
1	Communicable Diseases (Infectious Diseases) 11/2007
1	Infections 10/2005
1	Lung Injury 10/2005
1	Hematologic Diseases (Blood Diseases) 10/2005

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 07/2018 - 09/2004
3	Bleomycin (Blenoxane)FDA LinkGeneric 02/2016 - 03/2014
2	Crystallins (Crystallin)IBA 02/2015 - 03/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014 - 04/2013
2	nilutamide (Nilandron)FDA Link 01/2006 - 11/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	GasesIBA 10/2016
1	ponatinibIBA 02/2016
1	VemurafenibIBA 10/2015
1	trametinibIBA 10/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	AnticoagulantsIBA 08/2015
1	CarbonIBA 02/2015
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 02/2015
1	Minocycline (Cyclops)FDA LinkGeneric 09/2014
1	Amiodarone (Amiodarona)FDA LinkGeneric 09/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2014
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 09/2014
1	Small Heat-Shock ProteinsIBA 03/2014
1	Antineoplastic Agents (Antineoplastics)IBA 04/2013
1	apatorsenIBA 04/2013
1	Antisense OligonucleotidesIBA 04/2013
1	IsocyanatesIBA 06/2012
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2011
1	TOR Serine-Threonine KinasesIBA 08/2010
1	Everolimus FDA Link 08/2010
1	MTOR InhibitorsIBA 08/2010
1	AsbestosIBA 11/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2007
1	AndrogensIBA 01/2006
1	Androgen Antagonists (Antiandrogens)IBA 11/2004

Therapy/Procedure

5	Therapeutics 01/2019 - 11/2007
2	Drug Therapy (Chemotherapy) 01/2017 - 09/2014
2	Radiotherapy 09/2014 - 11/2007
1	Noninvasive Ventilation 10/2016
1	Nebulizers and Vaporizers (Inhaler) 01/2011
1	Pleurodesis 11/2007